Lead Product(s) : Rabeprazole Sodium,Levosulpiride
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Akums Launches Rabeprazole + Levosulpiride SR Capsules for GERD in India
Details : Rabeprazole sodium, a potent antisecretory compound, selectively inhibits gastric acid secretion by targeting the H+ and K+ ATPase, indicated for treating gastric and duodenal ulcers, as well as GERD.
Product Name : Rabeprazole-Levosulpiride-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 10, 2024
Lead Product(s) : Rabeprazole Sodium,Levosulpiride
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Rabeprazole Sodium
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Seoul National University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Rabeprazole Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Gastroesophageal Reflux.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 11, 2021
Lead Product(s) : Rabeprazole Sodium
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Seoul National University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
